Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
mcL 35 38 35 38 I-lower_bound

Adequate 0 8 39 47 O
archival 9 17 48 56 O
tissue 18 24 57 63 O
from 25 29 64 68 O
a 30 31 69 70 O
biopsy 32 38 71 77 B-treatment
performed 39 48 78 87 O
after 49 54 88 93 O
progression 55 66 94 105 O
of 67 69 106 108 O
disease 70 77 109 116 O
on 78 80 117 119 O
previous 81 89 120 128 O
EGFR 90 94 129 133 B-treatment
TKI 95 98 134 137 I-treatment

Any 0 3 138 141 O
clinically 4 14 142 152 O
important 15 24 153 162 O
abnormalities 25 38 163 176 O
in 39 41 177 179 O
rhythm 42 48 180 186 O
, 48 49 186 187 O
conduction 50 60 188 198 O
or 61 63 199 201 O
morphology 64 74 202 212 O
of 75 77 213 215 O
resting 78 85 216 223 O
electrocardiogram 86 103 224 241 O
( 104 105 242 243 O
ECG 105 108 243 246 O
) 108 109 246 247 O
( 110 111 248 249 O
e.g. 111 115 249 253 O
, 115 116 253 254 O
complete 117 125 255 263 B-chronic_disease
left 126 130 264 268 I-chronic_disease
bundle 131 137 269 275 I-chronic_disease
branch 138 144 276 282 I-chronic_disease
block 145 150 283 288 I-chronic_disease
, 150 151 288 289 O
third 152 157 290 295 B-chronic_disease
degree 158 164 296 302 I-chronic_disease
heart 165 170 303 308 I-chronic_disease
block 171 176 309 314 I-chronic_disease
, 176 177 314 315 O
second 178 184 316 322 B-chronic_disease
degree 185 191 323 329 I-chronic_disease
heart 192 197 330 335 I-chronic_disease
block 198 203 336 341 I-chronic_disease
) 203 204 341 342 O

Aspartate 0 9 343 352 B-clinical_variable
aminotransferase 10 26 353 369 I-clinical_variable
( 27 28 370 371 I-clinical_variable
AST 28 31 371 374 I-clinical_variable
) 31 32 374 375 I-clinical_variable
( 33 34 376 377 I-clinical_variable
serum 34 39 377 382 I-clinical_variable
glutamic 40 48 383 391 I-clinical_variable
oxaloacetic 49 60 392 403 I-clinical_variable
transaminase 61 73 404 416 I-clinical_variable
[ 74 75 417 418 I-clinical_variable
SGOT])/alanine 75 89 418 432 I-clinical_variable
aminotransferase 90 106 433 449 I-clinical_variable
( 107 108 450 451 I-clinical_variable
ALT 108 111 451 454 I-clinical_variable
) 111 112 454 455 I-clinical_variable
( 113 114 456 457 I-clinical_variable
serum 114 119 457 462 I-clinical_variable
glutamate 120 129 463 472 I-clinical_variable
pyruvate 130 138 473 481 I-clinical_variable
transaminase 139 151 482 494 I-clinical_variable
[ 152 153 495 496 I-clinical_variable
SGPT 153 157 496 500 I-clinical_variable
] 157 158 500 501 I-clinical_variable
) 158 159 501 502 I-clinical_variable
= 160 161 503 504 O
< 161 162 504 505 O
3.0 163 166 506 509 B-upper_bound
x 167 168 510 511 I-upper_bound
institutional 169 182 512 525 I-upper_bound
ULN 183 186 526 529 I-upper_bound

Congenital 0 10 530 540 B-chronic_disease
long 11 15 541 545 I-chronic_disease
QT 16 18 546 548 I-chronic_disease
syndrome 19 27 549 557 I-chronic_disease
or 28 30 558 560 O
family 31 37 561 567 O
history 38 45 568 575 O
of 46 48 576 578 O
long 49 53 579 583 O
QT 54 56 584 586 O
syndrome 57 65 587 595 O

Corticosteroids 0 15 596 611 B-treatment
prescribed 16 26 612 622 O
for 27 30 623 626 O
the 31 34 627 630 O
management 35 45 631 641 O
of 46 48 642 644 O
brain 49 54 645 650 B-cancer
metastases 55 65 651 661 I-cancer
have 66 70 662 666 O
been 71 75 667 671 O
discontinued 76 88 672 684 O
at 89 91 685 687 O
least 92 97 688 693 O
7 98 99 694 695 B-lower_bound
days 100 104 696 700 I-lower_bound
prior 105 110 701 706 I-lower_bound
to 111 113 707 709 O
registration 114 126 710 722 O

Creatinine 0 10 723 733 B-clinical_variable
= 11 12 734 735 O
< 12 13 735 736 O
2.0 14 17 737 740 B-upper_bound
mg 18 20 741 743 I-upper_bound
/ 20 21 743 744 I-upper_bound
dL 21 23 744 746 I-upper_bound

Creatinine 0 10 747 757 B-clinical_variable
clearance 11 20 758 767 I-clinical_variable
> 21 22 768 769 O
= 22 23 769 770 O
50 24 26 771 773 B-lower_bound
mL 27 29 774 776 I-lower_bound
/ 29 30 776 777 I-lower_bound
min 30 33 777 780 I-lower_bound

Eastern 0 7 781 788 B-clinical_variable
Cooperative 8 19 789 800 I-clinical_variable
Oncology 20 28 801 809 I-clinical_variable
Group 29 34 810 815 I-clinical_variable
( 35 36 816 817 I-clinical_variable
ECOG 36 40 817 821 I-clinical_variable
) 40 41 821 822 I-clinical_variable
performance 42 53 823 834 I-clinical_variable
status 54 60 835 841 I-clinical_variable
= 61 62 842 843 O
< 62 63 843 844 O
1 64 65 845 846 B-upper_bound
( 66 67 847 848 O
Karnofsky 67 76 848 857 B-clinical_variable
> 77 78 858 859 O
= 78 79 859 860 O
70 80 82 861 863 B-lower_bound
% 82 83 863 864 I-lower_bound
) 83 84 864 865 O

Hemoglobin 0 10 866 876 B-clinical_variable
> 11 12 877 878 O
= 12 13 878 879 O
8.0 14 17 880 883 B-lower_bound
g 18 19 884 885 I-lower_bound
/ 19 20 885 886 I-lower_bound
dL 20 22 886 888 I-lower_bound

Histologically 0 14 889 903 O
confirmed 15 24 904 913 O
non 25 28 914 917 B-cancer
- 28 29 917 918 I-cancer
squamous 29 37 918 926 I-cancer
NSCLC 38 43 927 932 I-cancer
, 43 44 932 933 O
with 45 49 934 938 O
incurable 50 59 939 948 O
advanced 60 68 949 957 B-cancer
or 69 71 958 960 I-cancer
metastatic 72 82 961 971 I-cancer
disease 83 90 972 979 I-cancer

History 0 7 980 987 O
of 8 10 988 990 O
hypersensitivity 11 27 991 1007 O
to 28 30 1008 1010 O
AZD9291 31 38 1011 1018 B-allergy_name
( 39 40 1019 1020 O
or 40 42 1020 1022 O
drugs 43 48 1023 1028 O
with 49 53 1029 1033 O
a 54 55 1034 1035 O
similar 56 63 1036 1043 O
chemical 64 72 1044 1052 O
structure 73 82 1053 1062 O
or 83 85 1063 1065 O
class 86 91 1066 1071 O
to 92 94 1072 1074 O
AZD9291 95 102 1075 1082 O
) 102 103 1082 1083 O
or 104 106 1084 1086 O
any 107 110 1087 1090 O
excipients 111 121 1091 1101 O
of 122 124 1102 1104 O
these 125 130 1105 1110 O
agents 131 137 1111 1117 O

Hormonal 0 8 1118 1126 O
contraceptives 9 23 1127 1141 O
( 24 25 1142 1143 O
oral 25 29 1143 1147 O
, 29 30 1147 1148 O
parenteral 31 41 1149 1159 O
, 41 42 1159 1160 O
transdermal 43 54 1161 1172 O
or 55 57 1173 1175 O
vaginal 58 65 1176 1183 O
ring 66 70 1184 1188 O
) 70 71 1188 1189 O
for 72 75 1190 1193 O
at 76 78 1194 1196 O
least 79 84 1197 1202 O
3 85 86 1203 1204 B-lower_bound
months 87 93 1205 1211 I-lower_bound
prior 94 99 1212 1217 I-lower_bound
to 100 102 1218 1220 O
study 103 108 1221 1226 O
drug 109 113 1227 1231 O
administration 114 128 1232 1246 O

Leukocytes 0 10 1247 1257 B-clinical_variable
> 11 12 1258 1259 O
= 12 13 1259 1260 O
3,000 14 19 1261 1266 B-lower_bound
/ 19 20 1266 1267 I-lower_bound
mcL 20 23 1267 1270 I-lower_bound

Life 0 4 1271 1275 B-clinical_variable
expectancy 5 15 1276 1286 I-clinical_variable
of 16 18 1287 1289 O
greater 19 26 1290 1297 O
than 27 31 1298 1302 O
3 32 33 1303 1304 B-lower_bound
months 34 40 1305 1311 I-lower_bound

Major 0 5 1312 1317 B-treatment
surgery 6 13 1318 1325 I-treatment
within 14 20 1326 1332 O
21 21 23 1333 1335 B-upper_bound
days 24 28 1336 1340 I-upper_bound
of 29 31 1341 1343 O
starting 32 40 1344 1352 O
protocol 41 49 1353 1361 O
treatment 50 59 1362 1371 B-treatment

Mean 0 4 1372 1376 B-clinical_variable
resting 5 12 1377 1384 I-clinical_variable
corrected 13 22 1385 1394 I-clinical_variable
QT 23 25 1395 1397 I-clinical_variable
interval 26 34 1398 1406 I-clinical_variable
( 35 36 1407 1408 O
QTc 36 39 1408 1411 B-clinical_variable
using 40 45 1412 1417 I-clinical_variable
Frederica 46 55 1418 1427 I-clinical_variable
's 55 57 1427 1429 I-clinical_variable
formula 58 65 1430 1437 I-clinical_variable
[ 66 67 1438 1439 I-clinical_variable
QTcF 67 71 1439 1443 I-clinical_variable
] 71 72 1443 1444 I-clinical_variable
) 72 73 1444 1445 O
> 74 75 1446 1447 O
470 76 79 1448 1451 B-lower_bound
msec 80 84 1452 1456 I-lower_bound

Past 0 4 1457 1461 O
medical 5 12 1462 1469 O
history 13 20 1470 1477 O
of 21 23 1478 1480 O
interstitial 24 36 1481 1493 B-chronic_disease
lung 37 41 1494 1498 I-chronic_disease
disease 42 49 1499 1506 I-chronic_disease
, 49 50 1506 1507 O
drug 51 55 1508 1512 O
- 55 56 1512 1513 O
induced 56 63 1513 1520 O
interstitial 64 76 1521 1533 O
lung 77 81 1534 1538 O
disease 82 89 1539 1546 O
, 89 90 1546 1547 O
radiation 91 100 1548 1557 B-chronic_disease
pneumonitis 101 112 1558 1569 I-chronic_disease
requiring 113 122 1570 1579 O
steroid 123 130 1580 1587 B-treatment
treatment 131 140 1588 1597 I-treatment
, 140 141 1597 1598 O
or 142 144 1599 1601 O
any 145 148 1602 1605 O
evidence 149 157 1606 1614 O
of 158 160 1615 1617 O
clinically 161 171 1618 1628 O
active 172 178 1629 1635 O
interstitial 179 191 1636 1648 O
lung 192 196 1649 1653 O
disease 197 204 1654 1661 O

Patients 0 8 1662 1670 O
with 9 13 1671 1675 O
a 14 15 1676 1677 O
prior 16 21 1678 1683 O
history 22 29 1684 1691 O
of 30 32 1692 1694 O
brain 33 38 1695 1700 B-cancer
metastases 39 49 1701 1711 I-cancer

Patients 0 8 1712 1720 O
with 9 13 1721 1725 O
a 14 15 1726 1727 O
recent 16 22 1728 1734 O
history 23 30 1735 1742 O
of 31 33 1743 1745 O
non 34 37 1746 1749 B-chronic_disease
- 37 38 1749 1750 I-chronic_disease
chemotherapy 38 50 1750 1762 I-chronic_disease
- 50 51 1762 1763 I-chronic_disease
induced 51 58 1763 1770 I-chronic_disease
thrombocytopenic 59 75 1771 1787 I-chronic_disease
- 75 76 1787 1788 O
associated 76 86 1788 1798 O
bleeding 87 95 1799 1807 O
within 96 102 1808 1814 O
1 103 104 1815 1816 B-upper_bound
year 105 109 1817 1821 I-upper_bound
prior 110 115 1822 1827 I-upper_bound
to 116 118 1828 1830 O
the 119 122 1831 1834 O
first 123 128 1835 1840 O
dose 129 133 1841 1845 O
of 134 136 1846 1848 O
study 137 142 1849 1854 O
drug 143 147 1855 1859 O

Patients 0 8 1860 1868 O
with 9 13 1869 1873 O
a 14 15 1874 1875 O
significant 16 27 1876 1887 O
history 28 35 1888 1895 O
of 36 38 1896 1898 O
cardiovascular 39 53 1899 1913 B-chronic_disease
disease 54 61 1914 1921 I-chronic_disease
( 62 63 1922 1923 O
e.g. 63 67 1923 1927 O
, 67 68 1927 1928 O
myocardial 69 79 1929 1939 B-chronic_disease
infarction 80 90 1940 1950 I-chronic_disease
[ 91 92 1951 1952 O
MI 92 94 1952 1954 O
] 94 95 1954 1955 O
, 95 96 1955 1956 O
thrombotic 97 107 1957 1967 B-chronic_disease
or 108 110 1968 1970 O
thromboembolic 111 125 1971 1985 B-chronic_disease
event 126 131 1986 1991 O
in 132 134 1992 1994 O
the 135 138 1995 1998 O
last 139 143 1999 2003 B-upper_bound
6 144 145 2004 2005 I-upper_bound
months 146 152 2006 2012 I-upper_bound
) 152 153 2012 2013 O

Patients 0 8 2014 2022 O
with 9 13 2023 2027 O
active 14 20 2028 2034 B-cancer
malignancies 21 33 2035 2047 I-cancer
other 34 39 2048 2053 O
than 40 44 2054 2058 O
NSCLC 45 50 2059 2064 B-cancer
or 51 53 2065 2067 O
patients 54 62 2068 2076 O
with 63 67 2077 2081 O
prior 68 73 2082 2087 B-treatment
curatively 74 84 2088 2098 I-treatment
treated 85 92 2099 2106 I-treatment
malignancy 93 103 2107 2117 I-treatment
at 104 106 2118 2120 O
high 107 111 2121 2125 O
risk 112 116 2126 2130 O
of 117 119 2131 2133 O
relapse 120 127 2134 2141 O
during 128 134 2142 2148 O
the 135 138 2149 2152 O
study 139 144 2153 2158 O
period 145 151 2159 2165 O
with 152 156 2166 2170 O
the 157 160 2171 2174 O
exception 161 170 2175 2184 O
of 171 173 2185 2187 O
localized 174 183 2188 2197 O
squamous 184 192 2198 2206 B-cancer
or 193 195 2207 2209 O
basal 196 201 2210 2215 B-cancer
cell 202 206 2216 2220 I-cancer
skin 207 211 2221 2225 I-cancer
cancers 212 219 2226 2233 I-cancer

Patients 0 8 2234 2242 O
with 9 13 2243 2247 O
human 14 19 2248 2253 B-chronic_disease
immunodeficiency 20 36 2254 2270 I-chronic_disease
virus 37 42 2271 2276 I-chronic_disease
( 43 44 2277 2278 I-chronic_disease
HIV 44 47 2278 2281 I-chronic_disease
) 47 48 2281 2282 I-chronic_disease
on 49 51 2283 2285 O
antiretroviral 52 66 2286 2300 B-treatment
therapy 67 74 2301 2308 I-treatment
are 75 78 2309 2312 O
ineligible 79 89 2313 2323 O
because 90 97 2324 2331 O
of 98 100 2332 2334 O
the 101 104 2335 2338 O
potential 105 114 2339 2348 O
for 115 118 2349 2352 O
pharmacokinetic 119 134 2353 2368 B-treatment
interactions 135 147 2369 2381 I-treatment
with 148 152 2382 2386 I-treatment
AZD9291 153 160 2387 2394 I-treatment

Patients 0 8 2395 2403 O
with 9 13 2404 2408 O
uncontrolled 14 26 2409 2421 O
intercurrent 27 39 2422 2434 O
illness 40 47 2435 2442 O
including 48 57 2443 2452 O
, 57 58 2452 2453 O
but 59 62 2454 2457 O
not 63 66 2458 2461 O
limited 67 74 2462 2469 O
to 75 77 2470 2472 O
, 77 78 2472 2473 O
ongoing 79 86 2474 2481 O
or 87 89 2482 2484 O
active 90 96 2485 2491 B-chronic_disease
infection 97 106 2492 2501 I-chronic_disease
, 106 107 2501 2502 O
symptomatic 108 119 2503 2514 O
congestive 120 130 2515 2525 B-chronic_disease
heart 131 136 2526 2531 I-chronic_disease
failure 137 144 2532 2539 I-chronic_disease
, 144 145 2539 2540 O
unstable 146 154 2541 2549 B-chronic_disease
angina 155 161 2550 2556 I-chronic_disease
pectoris 162 170 2557 2565 O
, 170 171 2565 2566 O
cardiac 172 179 2567 2574 B-chronic_disease
arrhythmia 180 190 2575 2585 I-chronic_disease
, 190 191 2585 2586 O
gastrointestinal 192 208 2587 2603 B-chronic_disease
disease 209 216 2604 2611 I-chronic_disease
limiting 217 225 2612 2620 O
absorption 226 236 2621 2631 O
of 237 239 2632 2634 O
AZD9291 240 247 2635 2642 B-treatment
such 248 252 2643 2647 O
as 253 255 2648 2650 O
a 256 257 2651 2652 O
malabsorption 258 271 2653 2666 B-treatment
syndrome 272 280 2667 2675 I-treatment
or 281 283 2676 2678 O
inflammatory 284 296 2679 2691 B-chronic_disease
bowel 297 302 2692 2697 I-chronic_disease
disease 303 310 2698 2705 I-chronic_disease
or 311 313 2706 2708 O
psychiatric 314 325 2709 2720 B-chronic_disease
illness 326 333 2721 2728 I-chronic_disease
/ 333 334 2728 2729 O
social 334 340 2729 2735 O
situations 341 351 2736 2746 O
that 352 356 2747 2751 O
would 357 362 2752 2757 O
limit 363 368 2758 2763 O
compliance 369 379 2764 2774 O
with 380 384 2775 2779 O
study 385 390 2780 2785 O
requirements 391 403 2786 2798 O

Platelets 0 9 2799 2808 B-clinical_variable
> 10 11 2809 2810 O
= 11 12 2810 2811 O
100,000 13 20 2812 2819 B-lower_bound
/ 20 21 2819 2820 I-lower_bound
mcL 21 24 2820 2823 I-lower_bound

Pregnant 0 8 2824 2832 B-pregnancy
women 9 14 2833 2838 B-gender

Prior 0 5 2839 2844 O
genotyping 6 16 2845 2855 O
positive 17 25 2856 2864 O
for 26 29 2865 2868 O
an 30 32 2869 2871 O
EGFR 33 37 2872 2876 B-cancer
activating 38 48 2877 2887 I-cancer
mutation 49 57 2888 2896 I-cancer
( 58 59 2897 2898 O
L858R 59 64 2898 2903 B-cancer
, 64 65 2903 2904 O
exon 66 70 2905 2909 B-cancer
19 71 73 2910 2912 I-cancer
deletion 74 82 2913 2921 I-cancer
, 82 83 2921 2922 O
G719X 84 89 2923 2928 B-cancer
, 89 90 2928 2929 O
L861Q 91 96 2930 2935 B-cancer
) 96 97 2935 2936 O

Progression 0 11 2937 2948 O
after 12 17 2949 2954 O
prior 18 23 2955 2960 B-treatment
treatment 24 33 2961 2970 I-treatment
with 34 38 2971 2975 O
an 39 41 2976 2978 O
EGFR 42 46 2979 2983 O
TKI 47 50 2984 2987 O

The 0 3 2988 2991 O
brain 4 9 2992 2997 B-cancer
metastases 10 20 2998 3008 I-cancer
are 21 24 3009 3012 O
stable 25 31 3013 3019 O
on 32 34 3020 3022 O
pre 35 38 3023 3026 O
- 38 39 3026 3027 O
registration 39 51 3027 3039 O
imaging 52 59 3040 3047 O

The 0 3 3048 3051 O
brain 4 9 3052 3057 B-cancer
metastases 10 20 3058 3068 I-cancer
have 21 25 3069 3073 O
been 26 30 3074 3078 O
treated 31 38 3079 3086 O

The 0 3 3087 3090 O
effects 4 11 3091 3098 O
of 12 14 3099 3101 O
AZD9291 15 22 3102 3109 B-treatment
and 23 26 3110 3113 O
navitoclax 27 37 3114 3124 B-treatment
on 38 40 3125 3127 O
the 41 44 3128 3131 O
developing 45 55 3132 3142 O
human 56 61 3143 3148 O
fetus 62 67 3149 3154 O
are 68 71 3155 3158 O
unknown 72 79 3159 3166 O
; 79 80 3166 3167 O
for 81 84 3168 3171 O
this 85 89 3172 3176 O
reason 90 96 3177 3183 O
, 96 97 3183 3184 O
women 98 103 3185 3190 B-gender
of 104 106 3191 3193 O
child 107 112 3194 3199 O
- 112 113 3199 3200 O
bearing 113 120 3200 3207 O
potential 121 130 3208 3217 O
and 131 134 3218 3221 O
men 135 138 3222 3225 O
must 139 143 3226 3230 O
agree 144 149 3231 3236 B-contraception_consent
to 150 152 3237 3239 I-contraception_consent
use 153 156 3240 3243 I-contraception_consent
adequate 157 165 3244 3252 I-contraception_consent
contraception 166 179 3253 3266 I-contraception_consent
using 180 185 3267 3272 O
one 186 189 3273 3276 O
of 190 192 3277 3279 O
the 193 196 3280 3283 O
methods 197 204 3284 3291 O
listed 205 211 3292 3298 O
below 212 217 3299 3304 O
prior 218 223 3305 3310 O
to 224 226 3311 3313 O
study 227 232 3314 3319 O
entry 233 238 3320 3325 O
, 238 239 3325 3326 O
for 240 243 3327 3330 O
the 244 247 3331 3334 O
duration 248 256 3335 3343 O
of 257 259 3344 3346 O
study 260 265 3347 3352 O
participation 266 279 3353 3366 O
, 279 280 3366 3367 O
and 281 284 3368 3371 O
for 285 288 3372 3375 O
3 289 290 3376 3377 B-upper_bound
months 291 297 3378 3384 I-upper_bound
for 298 301 3385 3388 O
women 302 307 3389 3394 O
and 308 311 3395 3398 O
6 312 313 3399 3400 B-upper_bound
months 314 320 3401 3407 I-upper_bound
for 321 324 3408 3411 O
men 325 328 3412 3415 O
following 329 338 3416 3425 O
the 339 342 3426 3429 O
date 343 347 3430 3434 O
of 348 350 3435 3437 O
the 351 354 3438 3441 O
last 355 359 3442 3446 O
dose 360 364 3447 3451 O
of 365 367 3452 3454 O
AZD9291 368 375 3455 3462 O
and/or 376 382 3463 3469 O
navitoclax 383 393 3470 3480 O

The 0 3 3481 3484 O
patient 4 11 3485 3492 O
is 12 14 3493 3495 O
asymptomatic 15 27 3496 3508 O
from 28 32 3509 3513 O
the 33 36 3514 3517 O
brain 37 42 3518 3523 B-cancer
metastases 43 53 3524 3534 I-cancer

Total 0 5 3535 3540 O
abstinence 6 16 3541 3551 O
from 17 21 3552 3556 O
sexual 22 28 3557 3563 O
intercourse 29 40 3564 3575 O
( 41 42 3576 3577 O
minimum 42 49 3577 3584 O
one 50 53 3585 3588 B-lower_bound
complete 54 62 3589 3597 O
menstrual 63 72 3598 3607 O
cycle 73 78 3608 3613 O
prior 79 84 3614 3619 O
to 85 87 3620 3622 O
study 88 93 3623 3628 O
drug 94 98 3629 3633 O
administration 99 113 3634 3648 O
) 113 114 3648 3649 O

Total 0 5 3650 3655 O
bilirubin 6 15 3656 3665 B-clinical_variable
= 16 17 3666 3667 O
< 17 18 3667 3668 O
1.5 19 22 3669 3672 O
x 23 24 3673 3674 O
ULN 25 28 3675 3678 O
( 29 30 3679 3680 O
patients 30 38 3680 3688 O
with 39 43 3689 3693 O
Gilbert 44 51 3694 3701 B-chronic_disease
's 51 53 3701 3703 I-chronic_disease
syndrome 54 62 3704 3712 I-chronic_disease
may 63 66 3713 3716 O
have 67 71 3717 3721 O
serum 72 77 3722 3727 B-clinical_variable
bilirubin 78 87 3728 3737 I-clinical_variable
> 88 89 3738 3739 O
1.5 90 93 3740 3743 O
x 94 95 3744 3745 O
ULN 96 99 3746 3749 O
) 99 100 3749 3750 O

Vasectomized 0 12 3751 3763 O
male 13 17 3764 3768 B-gender
subject 18 25 3769 3776 I-gender
or 26 28 3777 3779 O
vasectomized 29 41 3780 3792 O
partner 42 49 3793 3800 O
of 50 52 3801 3803 O
female 53 59 3804 3810 B-gender
subjects 60 68 3811 3819 I-gender

Women 0 5 3820 3825 B-gender
of 6 8 3826 3828 O
childbearing 9 21 3829 3841 O
potential 22 31 3842 3851 O
must 32 36 3852 3856 O
have 37 41 3857 3861 O
a 42 43 3862 3863 O
negative 44 52 3864 3872 B-pregnancy
urine 53 58 3873 3878 I-pregnancy
pregnancy 59 68 3879 3888 I-pregnancy
test 69 73 3889 3893 O
within 74 80 3894 3900 O
7 81 82 3901 3902 B-upper_bound
days 83 87 3903 3907 I-upper_bound
prior 88 93 3908 3913 I-upper_bound
to 94 96 3914 3916 O
initiation 97 107 3917 3927 O
of 108 110 3928 3930 O
treatment 111 120 3931 3940 O

a 0 1 3941 3942 O
woman 2 7 3943 3948 B-gender
become 8 14 3949 3955 O
pregnant 15 23 3956 3964 B-pregnancy
or 24 26 3965 3967 O
suspect 27 34 3968 3975 B-pregnancy
she 35 38 3976 3979 I-pregnancy
is 39 41 3980 3982 I-pregnancy
pregnant 42 50 3983 3991 I-pregnancy
while 51 56 3992 3997 O
she 57 60 3998 4001 O
or 61 63 4002 4004 O
her 64 67 4005 4008 O
partner 68 75 4009 4016 O
is 76 78 4017 4019 O
participating 79 92 4020 4033 O
in 93 95 4034 4036 O
this 96 100 4037 4041 O
study 101 106 4042 4047 O
, 106 107 4047 4048 O
she 108 111 4049 4052 O
should 112 118 4053 4059 O
inform 119 125 4060 4066 O
her 126 129 4067 4070 O
treating 130 138 4071 4079 O
physician 139 148 4080 4089 O
immediately 149 160 4090 4101 O

administration 0 14 4102 4116 O
of 15 17 4117 4119 O
heparin 18 25 4120 4127 B-treatment
to 26 28 4128 4130 O
keep 29 33 4131 4135 O
subject 34 41 4136 4143 O
's 41 43 4143 4145 O
infusion 44 52 4146 4154 O
lines 53 58 4155 4160 O
patent 59 65 4161 4167 O

agents 0 6 4168 4174 O
include 7 14 4175 4182 O
heparin 15 22 4183 4190 B-treatment
or 23 25 4191 4193 O
low 26 29 4194 4197 O
molecular 30 39 4198 4207 O
weight 40 46 4208 4214 O
heparin 47 54 4215 4222 O
, 54 55 4222 4223 O
warfarin 56 64 4224 4232 B-treatment
, 64 65 4232 4233 O
clopidogrel 66 77 4234 4245 B-treatment
, 77 78 4245 4246 O
ibuprofen 79 88 4247 4256 B-treatment
and 89 92 4257 4260 O
other 93 98 4261 4266 O
nonsteroidal 99 111 4267 4279 B-treatment
anti 112 116 4280 4284 I-treatment
- 116 117 4284 4285 I-treatment
inflammatory 117 129 4285 4297 I-treatment
drug 130 134 4298 4302 I-treatment
( 135 136 4303 4304 I-treatment
NSAIDS 136 142 4304 4310 I-treatment
) 142 143 4310 4311 I-treatment
, 143 144 4311 4312 O
tirofiban 145 154 4313 4322 B-treatment
, 154 155 4322 4323 O
and 156 159 4324 4327 O
other 160 165 4328 4333 O
anticoagulants 166 180 4334 4348 B-treatment
, 180 181 4348 4349 O
drugs 182 187 4350 4355 B-treatment
, 187 188 4355 4356 O
or 189 191 4357 4359 O
herbal 192 198 4360 4366 B-treatment
supplements 199 210 4367 4378 I-treatment
that 211 215 4379 4383 O
affect 216 222 4384 4390 O
platelet 223 231 4391 4399 B-clinical_variable
function 232 240 4400 4408 O

all 0 3 4409 4412 O
decisions 4 13 4413 4422 O
regarding 14 23 4423 4432 O
treatment 24 33 4433 4442 O
with 34 38 4443 4447 O
aspirin 39 46 4448 4455 B-treatment
therapy 47 54 4456 4463 I-treatment
will 55 59 4464 4468 O
be 60 62 4469 4471 O
determined 63 73 4472 4482 O
by 74 76 4483 4485 O
the 77 80 4486 4489 O
investigator 81 93 4490 4502 O
in 94 96 4503 4505 O
conjunction 97 108 4506 4517 O
with 109 113 4518 4522 O
the 114 117 4523 4526 O
medical 118 125 4527 4534 O
monitor 126 133 4535 4542 O

alopecia 0 8 4543 4551 B-clinical_variable
and 9 12 4552 4555 O
sensory 13 20 4556 4563 B-clinical_variable
neuropathy 21 31 4564 4574 I-clinical_variable
= 32 33 4575 4576 O
< 33 34 4576 4577 O
grade 35 40 4578 4583 B-upper_bound
2 41 42 4584 4585 I-upper_bound

aspirin 0 7 4586 4593 B-treatment
will 8 12 4594 4598 O
not 13 16 4599 4602 O
be 17 19 4603 4605 O
allowed 20 27 4606 4613 O
within 28 34 4614 4620 O
7 35 36 4621 4622 B-upper_bound
days 37 41 4623 4627 I-upper_bound
prior 42 47 4628 4633 I-upper_bound
to 48 50 4634 4636 O
the 51 54 4637 4640 O
first 55 60 4641 4646 O
dose 61 65 4647 4651 O
of 66 68 4652 4654 O
navitoclax 69 79 4655 4665 B-treatment
or 80 82 4666 4668 O
during 83 89 4669 4675 O
navitoclax 90 100 4676 4686 O
administration 101 115 4687 4701 O

be 0 2 4702 4704 O
treatment 3 12 4705 4714 O
naive 13 18 4715 4720 O
to 19 21 4721 4723 O
T790M 22 27 4724 4729 B-treatment
- 27 28 4729 4730 I-treatment
directed 28 36 4730 4738 I-treatment
EGFR 37 41 4739 4743 I-treatment
TKI 42 45 4744 4747 I-treatment

currently 0 9 4748 4757 O
receiving 10 19 4758 4767 O
( 20 21 4768 4769 O
or 21 23 4769 4771 O
unable 24 30 4772 4778 O
to 31 33 4779 4781 O
stop 34 38 4782 4786 O
use 39 42 4787 4790 O
at 43 45 4791 4793 O
least 46 51 4794 4799 O
1 52 53 4800 4801 B-lower_bound
week 54 58 4802 4806 I-lower_bound
prior 59 64 4807 4812 I-lower_bound
to 65 67 4813 4815 O
receiving 68 77 4816 4825 O
the 78 81 4826 4829 O
1st 82 85 4830 4833 O
dose 86 90 4834 4838 O
of 91 93 4839 4841 O
AZD9291 94 101 4842 4849 B-treatment
) 101 102 4849 4850 O
medications 103 114 4851 4862 B-treatment
or 115 117 4863 4865 O
herbal 118 124 4866 4872 B-treatment
supplements 125 136 4873 4884 I-treatment
known 137 142 4885 4890 O
to 143 145 4891 4893 O
be 146 148 4894 4896 O
potent 149 155 4897 4903 O
inhibitors 156 166 4904 4914 O
of 167 169 4915 4917 O
cytochrome 170 180 4918 4928 B-treatment
P450 181 185 4929 4933 I-treatment
, 185 186 4933 4934 O
family 187 193 4935 4941 B-treatment
2 194 195 4942 4943 I-treatment
, 195 196 4943 4944 O
subfamily 197 206 4945 4954 B-treatment
C 207 208 4955 4956 I-treatment
, 208 209 4956 4957 O
polypeptide 210 221 4958 4969 B-treatment
8 222 223 4970 4971 I-treatment
( 224 225 4972 4973 I-treatment
CYP2C8 225 231 4973 4979 I-treatment
) 231 232 4979 4980 I-treatment
and 233 236 4981 4984 O
potent 237 243 4985 4991 O
inhibitors 244 254 4992 5002 O
or 255 257 5003 5005 O
inducers 258 266 5006 5014 O
of 267 269 5015 5017 O
cytochrome 270 280 5018 5028 O
P450 281 285 5029 5033 O
, 285 286 5033 5034 O
family 287 293 5035 5041 B-treatment
3 294 295 5042 5043 I-treatment
, 295 296 5043 5044 O
subfamily 297 306 5045 5054 B-treatment
A 307 308 5055 5056 I-treatment
, 308 309 5056 5057 O
polypeptide 310 321 5058 5069 B-treatment
4 322 323 5070 5071 I-treatment
( 324 325 5072 5073 I-treatment
CYP3A4 325 331 5073 5079 I-treatment
) 331 332 5079 5080 I-treatment

have 0 4 5081 5085 O
a 5 6 5086 5087 O
tumor 7 12 5088 5093 B-cancer
which 13 18 5094 5099 O
is 19 21 5100 5102 O
EGFR 22 26 5103 5107 B-cancer
- 26 27 5107 5108 I-cancer
T790 27 31 5108 5112 I-cancer
M 31 32 5112 5113 I-cancer
positive 33 41 5114 5122 O

low 0 3 5123 5126 O
- 3 4 5126 5127 O
dose 4 8 5127 5131 O
anticoagulation 9 24 5132 5147 B-treatment
medications 25 36 5148 5159 I-treatment
that 37 41 5160 5164 O
are 42 45 5165 5168 O
used 46 50 5169 5173 O
to 51 53 5174 5176 O
maintain 54 62 5177 5185 O
the 63 66 5186 5189 O
patency 67 74 5190 5197 O
of 75 77 5198 5200 O
a 78 79 5201 5202 O
central 80 87 5203 5210 O
intravenous 88 99 5211 5222 O
catheter 100 108 5223 5231 O

male 0 4 5232 5236 B-gender
subjects 5 13 5237 5245 I-gender
( 14 15 5246 5247 O
including 15 24 5247 5256 O
those 25 30 5257 5262 O
who 31 34 5263 5266 O
are 35 38 5267 5270 O
vasectomized 39 51 5271 5283 O
) 51 52 5283 5284 O
whose 53 58 5285 5290 O
partners 59 67 5291 5299 O
are 68 71 5300 5303 B-pregnancy
pregnant 72 80 5304 5312 I-pregnancy
or 81 83 5313 5315 O
might 84 89 5316 5321 B-pregnancy
be 90 92 5322 5324 I-pregnancy
pregnant 93 101 5325 5333 I-pregnancy
must 102 106 5334 5338 O
agree 107 112 5339 5344 B-contraception_consent
to 113 115 5345 5347 I-contraception_consent
use 116 119 5348 5351 I-contraception_consent
condoms 120 127 5352 5359 I-contraception_consent
for 128 131 5360 5363 O
the 132 135 5364 5367 O
duration 136 144 5368 5376 O
of 145 147 5377 5379 O
the 148 151 5380 5383 O
study 152 157 5384 5389 O
and 158 161 5390 5393 O
6 162 163 5394 5395 O
months 164 170 5396 5402 O
following 171 180 5403 5412 O
completion 181 191 5413 5423 O
of 192 194 5424 5426 O
therapy 195 202 5427 5434 B-treatment

must 0 4 5435 5439 O
discontinue 5 16 5440 5451 O
previous 17 25 5452 5460 O
EGFR 26 30 5461 5465 B-treatment
- 30 31 5465 5466 I-treatment
TKI 31 34 5466 5469 I-treatment
at 35 37 5470 5472 O
least 38 43 5473 5478 O
7 44 45 5479 5480 B-lower_bound
days 46 50 5481 5485 I-lower_bound
prior 51 56 5486 5491 I-lower_bound
to 57 59 5492 5494 O
study 60 65 5495 5500 O
enrollment 66 76 5501 5511 O

must 0 4 5512 5516 O
have 5 9 5517 5521 O
completed 10 19 5522 5531 O
last 20 24 5532 5536 O
chemotherapy 25 37 5537 5549 B-treatment
> 38 39 5550 5551 O
= 39 40 5551 5552 O
3 41 42 5553 5554 B-lower_bound
weeks 43 48 5555 5560 I-lower_bound
or 49 51 5561 5563 O
radiotherapy 52 64 5564 5576 B-treatment
> 65 66 5577 5578 O
= 66 67 5578 5579 O
2 68 69 5580 5581 B-lower_bound
weeks 70 75 5582 5587 I-lower_bound
prior 76 81 5588 5593 I-lower_bound
to 82 84 5594 5596 O
receiving 85 94 5597 5606 O
study 95 100 5607 5612 O
drugs 101 106 5613 5618 O

must 0 4 5619 5623 O
have 5 9 5624 5628 O
recovered 10 19 5629 5638 O
from 20 24 5639 5643 O
adverse 25 32 5644 5651 O
events 33 39 5652 5658 O
attributable 40 52 5659 5671 O
to 53 55 5672 5674 O
previous 56 64 5675 5683 O
treatment 65 74 5684 5693 O
to 75 77 5694 5696 O
= 78 79 5697 5698 O
< 79 80 5698 5699 O
grade 81 86 5700 5705 B-upper_bound
1 87 88 5706 5707 I-upper_bound

prior 0 5 5708 5713 O
treatment 6 15 5714 5723 O
with 16 20 5724 5728 O
a 21 22 5729 5730 O
third 23 28 5731 5736 B-treatment
- 28 29 5736 5737 I-treatment
generation 29 39 5737 5747 I-treatment
EGFR 40 44 5748 5752 I-treatment
TKI 45 48 5753 5756 I-treatment
is 49 51 5757 5759 O
allowed 52 59 5760 5767 O
for 60 63 5768 5771 O
the 64 67 5772 5775 O
dose 68 72 5776 5780 O
escalation 73 83 5781 5791 O
phase 84 89 5792 5797 O
, 89 90 5797 5798 O
but 91 94 5799 5802 O
is 95 97 5803 5805 O
not 98 101 5806 5809 O
permitted 102 111 5810 5819 O
for 112 115 5820 5823 O
the 116 119 5824 5827 O
expansion 120 129 5828 5837 O
cohort 130 136 5838 5844 O

prothrombin 0 11 5845 5856 B-clinical_variable
time 12 16 5857 5861 I-clinical_variable
( 17 18 5862 5863 I-clinical_variable
PT 18 20 5863 5865 I-clinical_variable
) 20 21 5865 5866 I-clinical_variable
= 22 23 5867 5868 O
< 23 24 5868 5869 O
1.2 25 28 5870 5873 B-upper_bound
x 29 30 5874 5875 I-upper_bound
upper 31 36 5876 5881 I-upper_bound
limit 37 42 5882 5887 I-upper_bound
of 43 45 5888 5890 I-upper_bound
normal 46 52 5891 5897 I-upper_bound
( 53 54 5898 5899 O
ULN 54 57 5899 5902 O
) 57 58 5902 5903 O

receiving 0 9 5904 5913 O
anticoagulation 10 25 5914 5929 B-treatment
or 26 28 5930 5932 O
anti 29 33 5933 5937 B-treatment
- 33 34 5937 5938 I-treatment
platelet 34 42 5938 5946 I-treatment
therapy 43 50 5947 5954 I-treatment
are 51 54 5955 5958 O
excluded 55 63 5959 5967 O
due 64 67 5968 5971 O
to 68 70 5972 5974 O
the 71 74 5975 5978 O
risk 75 79 5979 5983 O
of 80 82 5984 5986 O
thrombocytopenia 83 99 5987 6003 B-chronic_disease
with 100 104 6004 6008 O
navitoclax 105 115 6009 6019 B-treatment

willing 0 7 6020 6027 O
to 8 10 6028 6030 O
undergo 11 18 6031 6038 O
a 19 20 6039 6040 O
new 21 24 6041 6044 O
tumor 25 30 6045 6050 B-treatment
biopsy 31 37 6051 6057 I-treatment
prior 38 43 6058 6063 O
to 44 46 6064 6066 O
registration 47 59 6067 6079 O
( 60 61 6080 6081 O
for 61 64 6081 6084 O
the 65 68 6085 6088 O
dose 69 73 6089 6093 O
escalation 74 84 6094 6104 O
portion 85 92 6105 6112 O
only 93 97 6113 6117 O
this 98 102 6118 6122 O
requirement 103 114 6123 6134 O
can 115 118 6135 6138 O
be 119 121 6139 6141 O
waived 122 128 6142 6148 O
if 129 131 6149 6151 O
T790 132 136 6152 6156 O
M 136 137 6156 6157 O
status 138 144 6158 6164 O
has 145 148 6165 6168 O
already 149 156 6169 6176 O
been 157 161 6177 6181 O
determined 162 172 6182 6192 O
using 173 178 6193 6198 O
a 179 180 6199 6200 O
local 181 186 6201 6206 O
assay 187 192 6207 6212 O
) 192 193 6212 6213 O

